These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28589533)

  • 1. Effects of exendin-4 and selenium on the expression of GLP-1R, IRS-1, and preproinsulin in the pancreas of diabetic rats.
    Barakat G; Moustafa ME; Khalifeh I; Hodroj MH; Bikhazi A; Rizk S
    J Physiol Biochem; 2016 Aug; 73(3):387-394. PubMed ID: 28589533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selenium and exendin-4 on glucagon-like peptide-1 receptor, IRS-1, and Raf-1 in the liver of diabetic rats.
    Barakat GM; Moustafa ME; Bikhazi AB
    Biochem Genet; 2012 Dec; 50(11-12):922-35. PubMed ID: 22983684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.
    Mi B; Xu Y; Pan D; Wang L; Yang R; Yu C; Wan W; Wu Y; Yang M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):47-51. PubMed ID: 26850848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
    Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Detroja J; Patel K; Gandhi T; Patel K; Bahekar R; Jain M
    Pharmacol Rep; 2013; 65(4):927-36. PubMed ID: 24145087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
    Himeno T; Kamiya H; Naruse K; Harada N; Ozaki N; Seino Y; Shibata T; Kondo M; Kato J; Okawa T; Fukami A; Hamada Y; Inagaki N; Seino Y; Drucker DJ; Oiso Y; Nakamura J
    Diabetes; 2011 Sep; 60(9):2397-406. PubMed ID: 21810596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 exerts its effects through the NGF/p75NTR system in diabetic mouse pancreas.
    Gezginci-Oktayoglu S; Bolkent S
    Biochem Cell Biol; 2009 Aug; 87(4):641-51. PubMed ID: 19767827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exendin-4 potentiates insulinotropic action partly via increasing beta-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats.
    Kwon DY; Kim YS; Ahn IS; Kim DS; Kang S; Hong SM; Park S
    J Pharmacol Sci; 2009 Dec; 111(4):361-71. PubMed ID: 20019445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucagon-like peptide-1(7-36) and exendin-4 on the vascular reactivity in streptozotocin/nicotinamide-induced diabetic rats.
    Ozyazgan S; Kutluata N; Afşar S; Ozdaş SB; Akkan AG
    Pharmacology; 2005 Jun; 74(3):119-26. PubMed ID: 15746570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and the biological effect of fusion protein GLP-1-exendin-4/ IgG4(Fc) fusion protein as long acting GLP-1 receptor agonist].
    Zheng YC
    Yao Xue Xue Bao; 2015 Dec; 50(12):1668-72. PubMed ID: 27169293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL; Huang Q; Cao X; Drucker DJ
    Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of the glucagonlike peptide 1 receptor in the pancreas with 68Ga-labeled DO3A-exendin-4.
    Selvaraju RK; Velikyan I; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Korsgren O; Eriksson O
    J Nucl Med; 2013 Aug; 54(8):1458-63. PubMed ID: 23761918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.
    Roan JN; Cheng HN; Young CC; Lee CJ; Yeh ML; Luo CY; Tsai YS; Lam CF
    J Surg Res; 2017 Feb; 208():93-103. PubMed ID: 27993221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats.
    Park S; Hong SM; Sung SR
    Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.
    Yang H; Li H; Wang Z; Shi Y; Jiang G; Zeng F
    J Surg Res; 2013 Dec; 185(2):825-32. PubMed ID: 23890403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide Induces Impairment of Autophagy Flux to Damage Rat Pancreas.
    Li Z; Huang L; Yu X; Yu C; Zhu H; Li X; Han D; Huang H
    Pancreas; 2017 Jan; 46(1):83-88. PubMed ID: 27518464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
    Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.